Post by PressReleaseon Dec 10, 2024 7:31am
21 Views
Post# 36354215
New Press Release - Quantum Biopharma Announces That the Safety Review Committee Recommends Commencing Dosing of Second Cohort in the Phase 1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-MS)